Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2020

Sep 24, 2020

6990_dirs_2020-09-24_deb5bfb6-64d9-44d5-9267-c732ed682f44.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2020-09-23

Reporting Person: CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-09-23 Common Stock P 8458 $9.05 Acquired 3738195 Direct
2020-09-23 Common Stock P 2276 $8.98 Acquired 3740471 Direct